Blank AT, Larson BM, Shaw S, Wakefield CJ, King T, Jones KB, Randall RL. National Comprehensive Cancer Network guidelines compliance of a sarcoma service: A retrospective review. World J Clin Oncol 2020; 11(6): 389-396 [PMID: 32874952 DOI: 10.5306/wjco.v11.i6.389]
Corresponding Author of This Article
Alan T Blank, MD, MSc, Assistant Professor, Attending Doctor, Department of Orthopedic Surgery, Division of Oncology, Rush University Medical Center, 1653 West Congress Parkway, Chicago, IL 60612, United States. alan.blank@rushortho.com
Research Domain of This Article
Orthopedics
Article-Type of This Article
Retrospective Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Oncol. Jun 24, 2020; 11(6): 389-396 Published online Jun 24, 2020. doi: 10.5306/wjco.v11.i6.389
National Comprehensive Cancer Network guidelines compliance of a sarcoma service: A retrospective review
Alan T Blank, Brandon Michael Larson, Sara Shaw, Connor J Wakefield, Tricia King, Kevin B Jones, R Lor Randall
Alan T Blank, Brandon Michael Larson, Connor J Wakefield, Department of Orthopedic Surgery, Division of Oncology, Rush University Medical Center, Chicago, IL 60612, United States
Sara Shaw, Tricia King, Kevin B Jones, Department of Orthopedics, University of Utah, Salt Lake City, UT 84108, United States
R Lor Randall, Department of Orthopedic Surgery, University of California-Davis Medical Center, Sacramento, CA 95817, United States
Author contributions: All authors contributed to this research study; Blank AT performed the procedures; Blank AT, Jones KB, Randall RL contributed to the critical revision of manuscript, conception and design, and project supervision; Larson BM and Wakefield CJ contributed to the analysis and interpretation of data; Shaw S, Larson BM and Wakefield CJ wrote the manuscript.
Institutional review board statement: This study was reviewed and approved by the University of Utah Medical Center Institutional Review Board and Research Integrity and Compliance office.
Informed consent statement: Patients were not required to give informed consent for this retrospective study. All data obtained and used for analysis remained anonymous and was obtained through routine clinical care.
Conflict-of-interest statement: All authors declare no conflicts-of-interest related to this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Alan T Blank, MD, MSc, Assistant Professor, Attending Doctor, Department of Orthopedic Surgery, Division of Oncology, Rush University Medical Center, 1653 West Congress Parkway, Chicago, IL 60612, United States. alan.blank@rushortho.com
Received: February 20, 2020 Peer-review started: February 20, 2020 First decision: April 25, 2020 Revised: May 9, 2020 Accepted: May 19, 2020 Article in press: May 19, 2020 Published online: June 24, 2020 Processing time: 125 Days and 8.7 Hours
Core Tip
Core tip: Clinical practice guidelines are necessary to ensure patients are treated equally and appropriately across all scenarios. This study is the first to investigate provider’s compliance with the National Comprehensive Cancer Network (NCCN) guidelines on sarcoma. The findings from this study demonstrate that compliance with NCCN sarcoma guidelines is high within a single National Cancer Institute designated center. Although in other cancer diagnoses improved survival has been documented with compliance of NCCN guidelines it is currently unknown whether this observation applies to sarcoma. We feel this manuscript will encourage future research in the impact of NCCN guidelines on the outcomes of patients with sarcoma who are treated at both National Cancer Institute designated and non-designated centers.
